Trial intelligence / Profile preview

Vonoprazan vs acotiamide in functional dyspepsia

jRCTs031190175Completed

Sponsor
Yokohama City University
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in functional dyspepsia (FD) comparing Vonoprazan arm with Acotiamide arm (2 arms). Primary endpoint: Elimination rate of all FD symptoms after 4 weeks. Started Jan 2020; status: completed.

02

Drugs

vonoprazanacotiamide
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on jRCTs031190175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031190175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call